JP2016510414A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510414A5
JP2016510414A5 JP2015557553A JP2015557553A JP2016510414A5 JP 2016510414 A5 JP2016510414 A5 JP 2016510414A5 JP 2015557553 A JP2015557553 A JP 2015557553A JP 2015557553 A JP2015557553 A JP 2015557553A JP 2016510414 A5 JP2016510414 A5 JP 2016510414A5
Authority
JP
Japan
Prior art keywords
biomarker
evaluated
sample
biological sample
quality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015557553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510414A (ja
JP6388606B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059002 external-priority patent/WO2014125443A1/en
Publication of JP2016510414A publication Critical patent/JP2016510414A/ja
Publication of JP2016510414A5 publication Critical patent/JP2016510414A5/ja
Application granted granted Critical
Publication of JP6388606B2 publication Critical patent/JP6388606B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015557553A 2013-02-14 2014-02-14 生物学的サンプルの質を評価するための手段及び方法 Expired - Fee Related JP6388606B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201361764625P 2013-02-14 2013-02-14
US201361764640P 2013-02-14 2013-02-14
US61/764,640 2013-02-14
EP13155310 2013-02-14
EP13155310.9 2013-02-14
EP13155318 2013-02-14
US61/764,625 2013-02-14
EP13155318.2 2013-02-14
PCT/IB2014/059002 WO2014125443A1 (en) 2013-02-14 2014-02-14 Means and methods for assessing the quality of a biological sample

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018152554A Division JP2019039915A (ja) 2013-02-14 2018-08-14 生物学的サンプルの質を評価するための手段及び方法

Publications (3)

Publication Number Publication Date
JP2016510414A JP2016510414A (ja) 2016-04-07
JP2016510414A5 true JP2016510414A5 (enExample) 2017-03-16
JP6388606B2 JP6388606B2 (ja) 2018-09-12

Family

ID=51353544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015557553A Expired - Fee Related JP6388606B2 (ja) 2013-02-14 2014-02-14 生物学的サンプルの質を評価するための手段及び方法

Country Status (11)

Country Link
US (1) US20160003799A1 (enExample)
EP (1) EP2956127A4 (enExample)
JP (1) JP6388606B2 (enExample)
KR (1) KR20150119118A (enExample)
CN (1) CN105120852A (enExample)
AU (1) AU2014217452B2 (enExample)
BR (1) BR112015019453A2 (enExample)
CA (1) CA2900031A1 (enExample)
DE (1) DE112014000822T5 (enExample)
IL (1) IL240346A0 (enExample)
WO (1) WO2014125443A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015237804A1 (en) * 2014-03-26 2016-09-22 Metanomics Health Gmbh Means and methods for determination of quality of blood samples based on metabolite panel
CN104713970B (zh) * 2015-04-01 2017-03-15 山东省肿瘤医院 一种血清代谢组学分析模型的构建方法
US10890592B2 (en) 2015-11-04 2021-01-12 Metabolon, Inc. Automated sample quality assessment
CN105996126B (zh) * 2016-07-12 2019-06-14 福建中烟工业有限责任公司 天冬氨酸甘油酯用于降低卷烟烟气中苯酚释放量的用途
JP6779500B2 (ja) * 2017-03-30 2020-11-04 株式会社島津製作所 クロマトグラフ質量分析方法及び装置
WO2018203885A1 (en) * 2017-05-02 2018-11-08 Liquid Biosciences, Inc. Systems and methods for determining attributes of biological samples
CN113167782B (zh) * 2018-10-30 2025-07-11 私募蛋白质体操作有限公司 用于样品质量评估的方法
JP7348626B2 (ja) * 2019-07-17 2023-09-21 国立大学法人山梨大学 生体試料の状態評価装置、システム、方法、およびプログラム
CN111402961B (zh) * 2020-02-28 2020-11-17 上海鹿明生物科技有限公司 一种多物种gc-ms内源性代谢物数据库及其建立方法
CN116297938A (zh) * 2021-06-25 2023-06-23 郑州大学第一附属医院 3-Methylxanthine在贲门癌诊断中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232396A1 (en) * 2002-02-22 2003-12-18 Biolife Solutions, Inc. Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant
WO2007064294A1 (en) * 2005-11-29 2007-06-07 Denator Aktiebolag Method for determining the quality of a biological sample
US8026049B2 (en) * 2007-03-23 2011-09-27 Wisconsin Alumni Research Foundation Noninvasive measurement and identification of biomarkers in disease state
EP2164977B1 (en) * 2007-07-17 2013-10-30 Metabolon, Inc. Biomarkers for pre-diabetes and methods using the same
WO2009066787A1 (ja) * 2007-11-22 2009-05-28 Japan Advanced Institute Of Science And Technology 血液試料の品質評価方法
PT2254586E (pt) * 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
US8026102B2 (en) * 2009-01-21 2011-09-27 Blaze Medical Devices, LLC Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
CA2778226A1 (en) * 2009-10-09 2011-04-14 Carolyn Slupsky Methods for diagnosis, treatment and monitoring of patient health using metabolomics
WO2012170669A1 (en) * 2011-06-07 2012-12-13 Yale University Avenue Biomarkers for assessment of the molecular quality in biospecimens

Similar Documents

Publication Publication Date Title
Kokkali et al. Overview of commercially available bioassays for assessing chemical toxicity in aqueous samples
JP2017512996A5 (enExample)
AU2018260845A1 (en) Evaluation and treatment of bradykinin-mediated disorders
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
MY198335A (en) Urinalysis Device and Dry Reagent for Quantitative Urinalysis
MX387805B (es) Medicion rapida de la tasa de sedimentacion de los componentes sanguineos formados a partir de pequeños volumenes de muestra.
MX372784B (es) Medicion rapida de la tasa de sedimentacion de los componentes sanguineos formados a partir de pequeños volumenes de muestra.
JP2017015710A5 (enExample)
EP2610621A3 (en) Blood cell analyzer, blood cell analyzing method, and non-transitory storage medium
WO2019028470A3 (en) Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets
JP2016505840A5 (enExample)
WO2015100459A3 (en) Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
JP2017181377A5 (enExample)
MX2019000591A (es) Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma.
MX377788B (es) Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana.
JP2020056595A5 (enExample)
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
EP4339295A3 (en) Storage device, system and method for determining the metabolic state of red blood cells and platelets
WO2014169072A3 (en) Kits and methods for separating a target analyte from a suspension
JP2014512546A5 (enExample)
WO2012122242A3 (en) Compositions and methods for determining risk of a cardiovascular occlusive event
EA201892046A1 (ru) Термопары, содержащие полимерное покрытие, для обнаружения аналитов и связанные способы
JP2015224889A5 (enExample)
WO2015193552A3 (en) Means and methods for determining risk of type-1 diabetes by serum protein biomarkers